» Articles » PMID: 30619104

Resveratrol-Mediated Attenuation of Enterotoxin B-Induced Acute Liver Injury Is Associated With Regulation of MicroRNA and Induction of Myeloid-Derived Suppressor Cells

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2019 Jan 9
PMID 30619104
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Resveratrol (RES) is a polyphenolic compound found abundantly in plant products including red grapes, peanuts, and mulberries. Because of potent anti-inflammatory properties of RES, we investigated whether RES can protect from Staphylococcal enterotoxin B (SEB)-induced acute liver injury in mice. SEB is a potent super antigen that induces robust inflammation and releases inflammatory cytokines that can be fatal. We observed that SEB caused acute liver injury in mice with increases in enzyme aspartate transaminase (AST) levels, and massive infiltration of immune cells into the liver. Treatment with RES (100 mg/kg body weight) attenuated SEB-induced acute liver injury, as indicated by decreased AST levels and cellular infiltration in the liver. Interestingly, RES treatment increased the number of myeloid derived suppressor cells (MDSCs) in the liver. RES treatment led to alterations in the microRNA (miR) profile in liver mononuclear cells (MNCs) of mice exposed to SEB, and pathway analysis indicated these miRs targeted many inflammatory pathways. Of these, we identified miR-185, which was down-regulated by RES, to specifically target Colony Stimulating Factor (CSF1) using transfection studies. Moreover, the levels of CSF1 were significantly increased in RES-treated SEB mice. Because CSF1 is critical in MDSC induction, our studies suggest that RES may induce MDSCs by down-regulating miR-185 leading to increase the expression of CSF1. The data presented demonstrate for the first time that RES can effectively attenuates SEB-induced acute liver injury and that this may result from its action on miRs and induction of MDSCs.

Citing Articles

Effect of Resveratrol and Curcumin on Gene Expression of Methicillin-Resistant (MRSA) Toxins.

El-Mahdy A, Alqahtani M, Almukainzi M, Alghoribi M, Abdel-Rhman S J Microbiol Biotechnol. 2023; 34(1):141-148.

PMID: 37986579 PMC: 10840468. DOI: 10.4014/jmb.2309.09001.


Targeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases.

Cannon A, Nagarkatti P, Nagarkatti M Int J Mol Sci. 2022; 23(1).

PMID: 35008717 PMC: 8745713. DOI: 10.3390/ijms23010288.


Umbilical cord miRNAs to predict neonatal early onset sepsis.

Ernst L, Mithal L, Mestan K, Wang V, Mangold K, Freedman A PLoS One. 2021; 16(5):e0249548.

PMID: 33961620 PMC: 8104380. DOI: 10.1371/journal.pone.0249548.


AhR Ligands Differentially Regulate miRNA-132 Which Targets HMGB1 and to Control the Differentiation of Tregs and Th-17 Cells During Delayed-Type Hypersensitivity Response.

Abdulla O, Neamah W, Sultan M, Chatterjee S, Singh N, Nagarkatti M Front Immunol. 2021; 12:635903.

PMID: 33679792 PMC: 7933657. DOI: 10.3389/fimmu.2021.635903.


Administration of Δ9-Tetrahydrocannabinol (THC) Post-Staphylococcal Enterotoxin B Exposure Protects Mice From Acute Respiratory Distress Syndrome and Toxicity.

Mohammed A, Alghetaa H, Sultan M, Singh N, Nagarkatti P, Nagarkatti M Front Pharmacol. 2020; 11:893.

PMID: 32612530 PMC: 7308536. DOI: 10.3389/fphar.2020.00893.


References
1.
Dinges M, Orwin P, Schlievert P . Exotoxins of Staphylococcus aureus. Clin Microbiol Rev. 2000; 13(1):16-34, table of contents. PMC: 88931. DOI: 10.1128/CMR.13.1.16. View

2.
Cauley L, Miller E, Yen M, Swain S . Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma. J Immunol. 2000; 165(11):6056-66. DOI: 10.4049/jimmunol.165.11.6056. View

3.
Gabrilovich D, Velders M, Sotomayor E, Kast W . Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J Immunol. 2001; 166(9):5398-406. DOI: 10.4049/jimmunol.166.9.5398. View

4.
Jang J, Surh Y . Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells. Mutat Res. 2001; 496(1-2):181-90. DOI: 10.1016/s1383-5718(01)00233-9. View

5.
Madsen J . Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. Clin Lab Med. 2001; 21(3):593-605. View